Clinical Trial Update: Efficacy and Tolerability of Riluzole in Treatment Resistant Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on riluzole for treatment-resistant depression, reporting efficacy and tolerability with completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: Yale University | Conditions: Depression | Phase 2 | Status: COMPLETED | Results posted: 2018-02-08